HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Brizantin

a complex preparation that includes ultra-low doses of antibodies against type 1 cannabinoid receptors and against S100 protein

Networked: 3 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Brizantin: 3
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Brizantin: 3
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Brizantin: 3
Pharmaceutical Preparations
- Drug Combinations: 5337
  - Brizantin: 3

Experts

1.	Epstein, O I: 2 articles (11/2015 - 01/2013)
2.	Andriambeloson, Emile: 1 article (04/2018)
3.	Epstein, Oleg I: 1 article (04/2018)
4.	Ertuzun, Irina A: 1 article (04/2018)
5.	Ivashkin, Vladimir T: 1 article (04/2018)
6.	Kardash, Elena V: 1 article (04/2018)
7.	Khakimova, Gul'nara R: 1 article (04/2018)
8.	Kolyadin, Andrey N: 1 article (04/2018)
9.	Tarasov, Sergey A: 1 article (04/2018)
10.	Wagner, Stéphanie: 1 article (04/2018)

Related Diseases

1.	Tobacco Use Disorder (Nicotine Dependence) 01/01/2013 - "Experimental study on the efficacy of the drug Brizantin in the model of nicotine dependence." 01/01/2013 - "We estimated the efficacy of Brizantin preparation in suppressing nicotine dependence in rats. " 01/01/2013 - "Thus, Brizantin effectively diminished nicotine dependence in rats in the model of nicotine addiction." 04/01/2018 - "Earlier studies have shown that combination of antibodies to S100 protein and to cannabinoid receptor type 1 in released-active form (Brizantin) may possess anxiolytic properties and decrease nicotine dependence. "
2.	Vertigo (Positional Vertigo) 11/01/2015 - "The effectiveness of antibody-based release-active preparations Impaza (antibodies to eNOS), Tenoten (antibodies to brain-specific protein S-100), Dietressa (antibodies to type 1 cannabinoid receptor), Brizantin (combined preparation, antibodies to brain-specific protein S-100 and type 1 cannabinoid receptor), and Divaza (combined preparation, antibodies to brain-specific protein S-100 and eNOS) in the prevention of vertigo was studied on the model of intermittent accumulation of Coriolis accelerations (ICCA). "

Related Drugs and Biologics

1.	Cannabinoid Receptors (Cannabinoid Receptor)
2.	Antibodies
3.	Anti-Anxiety Agents (Anxiolytics)
4.	S100 Proteins (S 100 Protein)
5.	Protein S
6.	IMPAZA
7.	tenoten
8.	divaza
9.	Dietressa